Abdominal Aortic Aneurysm Repair Market Size Projected to Reach USD 8.60 Billion by 2035 Driven by Advancements in Endovascular Procedures and Growing Aging Population

According to Precedence Research, the global abdominal aortic aneurysm (AAA) repair market size is projected to grow from USD 5.23 billion in 2025 to approximately USD 8.60 billion by 2035, expanding at a CAGR of 6.10% from 2026 to 2035. Key drivers of this expansion include the rising prevalence of abdominal aortic aneurysms, the aging population, and a strong shift towards minimally invasive endovascular aneurysm repair (EVAR) techniques. As technology continues to advance, the AAA repair market is poised for continuous innovation, offering improved patient outcomes and reduced complications.

The Full Study is Readily Available 📥 Download Sample Pages of the Report 👉 https://www.precedenceresearch.com/sample/8243

Role of AI in Abdominal Aortic Aneurysm Repair Market

Artificial Intelligence (AI) is making remarkable strides in the healthcare industry, and the AAA repair market is no exception. AI technologies are increasingly being applied in diagnostic tools, predictive modeling, and treatment planning. These advancements have enhanced the precision of repair surgeries, particularly in the Endovascular Aneurysm Repair (EVAR) techniques. AI-based platforms are helping to refine surgical planning by predicting potential complications and improving patient outcomes.

As AI continues to evolve, its role in the AAA repair market is expected to increase, providing more personalized treatment plans, efficient patient management, and potentially reducing healthcare costs. These technologies are particularly beneficial in high-risk surgeries, where accurate assessments can drastically improve survival rates.

Power Your Strategy with Full Market Data 👉 https://www.precedenceresearch.com/abdominal-aortic-aneurysm-repair-market

Abdominal Aortic Aneurysm Repair Market Size and Forecasts

🔹 Market size in 2025: USD 5.23 Billion
🔹 Market size in 2026: USD 5.50 Billion
🔹 Market size by 2035: USD 8.60 Billion
🔹 CAGR: 6.10% (2026-2035)
🔹 Forecast period: 2026-2035
🔹 Base year: 2025

Abdominal Aortic Aneurysm Repair Market Key Growth Drivers

🔸 Minimally Invasive Procedures: The growing preference for EVAR, due to its lower risk of complications and quicker recovery times, continues to drive market growth. Early detection through enhanced screening programs is also fueling demand for timely interventions.

🔸 Aging Population: As the global population ages, the incidence of abdominal aortic aneurysms is on the rise, contributing to a higher demand for repair procedures.

➡️ Become a valued research partner with us https://www.precedenceresearch.com/schedule-meeting

Abdominal Aortic Aneurysm Repair Market Opportunities

🔸 Technological Advancements: Continuous innovation in stent grafts, AI, and imaging technologies presents significant growth opportunities in the market.

🔸 Expansion in Emerging Markets: Increased healthcare infrastructure investments and government support in developing economies provide substantial growth opportunities in regions like Asia-Pacific and Latin America.

Abdominal Aortic Aneurysm Repair Market Trends

🔸 Minimally Invasive Treatments: The rising demand for minimally invasive procedures, especially EVAR, is reshaping the market. EVAR offers advantages such as smaller incisions, less blood loss, shorter hospital stays, and faster recovery, making it the preferred choice for both patients and healthcare providers.

🔸 Technological Innovations: Advances in stent graft technology, imaging systems, and navigation tools are revolutionizing the precision and efficacy of aneurysm repair. These innovations have expanded treatment possibilities for complex anatomies, leading to improved clinical outcomes.

🔸 AI Integration: Artificial intelligence (AI) is transforming the diagnosis and post-surgical care of abdominal aortic aneurysms. AI-driven imaging techniques enhance early detection, assess rupture risks, and support personalized treatment planning, ultimately improving patient outcomes.

🔓 Premium Market Intelligence - Delivered Instantly 📥 Buy the Premium Market Research Report Now 👉 https://www.precedenceresearch.com/checkout/8243

Abdominal Aortic Aneurysm Repair Market Regional Analysis

North America led the market with a 41% share in 2025, driven by advanced healthcare infrastructure, high procedure volumes, and strong screening programs. Investments in hybrid operating rooms, modern imaging systems, and favorable reimbursement policies support continued growth.

Asia Pacific is projected to grow at the fastest rate due to rising cardiovascular disease prevalence, an aging population, and improving healthcare infrastructure. Increased awareness, better screening programs, and expanding medical device availability are accelerating market expansion in the region.

Abdominal Aortic Aneurysm Repair Market Segment Analysis

🔹 Treatment Type Analysis

Endovascular Aneurysm Repair (EVAR) dominated the abdominal aortic aneurysm repair market with a 75% share in 2025. Its minimally invasive nature, reduced blood loss, shorter hospital stays, and faster recovery make it a preferred alternative to open surgery. Advancements in stent grafts, imaging, and catheter-based delivery systems have further improved its precision and outcomes, while increasing awareness and screening programs continue to drive adoption.

Open Surgical Repair (OSR) accounted for 25% of the market in 2025 and is expected to grow steadily. It remains essential for treating complex or large aneurysms unsuitable for EVAR. Improvements in surgical techniques, anesthesia, and postoperative care are enhancing patient outcomes and supporting its continued use in high-risk cases.

🔹 Product Type Analysis

Stent grafts (endografts) held a dominant 70% market share in 2025. Their widespread use in EVAR procedures, combined with benefits like lower perioperative risks and faster recovery, drives their demand. Ongoing innovations in flexibility, biocompatibility, and customization have expanded their use across various aneurysm types.

Catheters and delivery systems are projected to grow at a CAGR of 5.1% through 2035. Increasing reliance on minimally invasive procedures and advancements in navigation, precision, and steerability are boosting demand, particularly for complex aneurysm treatments.

🔹 Aneurysm Site Analysis

Infrarenal abdominal aortic aneurysms led the market with a 72% share in 2025 due to their high prevalence and suitability for EVAR procedures. Early detection through screening and improved device technologies have enhanced treatment success and expanded patient eligibility.

Pararenal aneurysms are expected to grow at the fastest rate, with a CAGR of 5.2%. Their complexity and proximity to renal arteries require advanced and customized treatment approaches. Innovations in specialized stent grafts and hybrid techniques are improving outcomes and driving segment growth.

🔹 End-User Analysis

Hospitals dominated the market with a 78% share in 2025. Their advanced infrastructure, access to specialized equipment, and ability to manage complex cases make them the primary centers for aneurysm repair. Strong referral networks and comprehensive care further reinforce their leadership.

Ambulatory Surgical Centers (ASCs) are expected to grow at a CAGR of 5.4%. Their cost-effectiveness, shorter stays, and convenience are attracting patients, especially for minimally invasive EVAR procedures. Expanding healthcare access and insurance coverage are supporting this trend.

🔹 Technique Analysis

Standard EVAR held a 55% share in 2025 due to its safety, efficiency, and minimal invasiveness. It reduces complications, hospital stays, and recovery time, making it widely adopted across hospitals and vascular centers.

Fenestrated EVAR (FEVAR) and branched/hybrid EVAR are gaining traction, with FEVAR expected to grow at a CAGR of 5.5%. These techniques enable treatment of complex aneurysms near critical arteries, supported by advancements in customized grafts and imaging technologies.

Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.

Try Before You Buy - Get the Sample Report@ https://www.precedenceresearch.com/sample/8243

Abdominal Aortic Aneurysm Repair Market Key Players and Their Offerings

➢ Medtronic plc
↳ EVAR stent‐graft systems such as the Endurant and Valiant platforms (fenestrated/branched variants for complex AAA and thoracoabdominal anatomy).
↳ A broad portfolio of endovascular AAA stent‐grafts with modular designs, dual‐layer technology, and various fixation options (barbs, cuffs, scallops) for standard and challenging anatomies.

➢ W. L. Gore & Associates
↳ GORE® EXCLUDER® AAA Endoprosthesis: main bifurcated stent‐graft platform for infrarenal AAA, noted for low‐profile delivery and modular design.
↳ Related off‐the‐shelf and custom branch/endoprosthesis solutions (e.g., TAMBE for thoracoabdominal/pararenal disease that overlaps with AAA‐adjacent indications).

➢ Cook Medical
↳ Zenith® family of AAA stent‐grafts, including infrarenal, fenestrated (Zenith Alpha), and periscope‐based solutions for short‐neck and complex aneurysms.
↳ Accessories such as iliac fixation devices (C3), delivery systems, and peripheral endografts that support AAA and EVAR‐related procedures.

➢ Terumo Corporation (Terumo Aortic)
↳ TREO® AAA Stent‐Graft System: modular, three‐piece EVAR platform with dual proximal fixation and in‐situ limb adjustability for tailored fit.
↳ Cardiatis® and other aortic stent‐grafts aimed at infrarenal AAA and complex aortic aneurysms, often marketed under the Terumo Aortic brand.

➢ Endologix LLC (now part of W. L. Gore)
↳ Historically focused on Nellix® EndoVascular Aneurysm Sealing (EVAS) system using sac‐filling polymer for AAA, plus AorfixTM and V12 stent‐grafts for tortuous anatomy.
↳ These technologies are now integrated into Gore's broader AAA/EVAR portfolio, supporting niche high‐risk or tortuous cases.

➢ Cardinal Health
↳ Primarily a distributor/integrator of third‐party AAA and EVAR devices (stent‐grafts, catheters, grafts) rather than a device manufacturer.
↳ Offers supply‐chain, procedural‐kit, and surgical‐device services that bundle AAA‐repair‐related products for hospitals and clinics.

➢ Boston Scientific Corporation
↳ Provides peripheral vascular and embolization devices that support AAA‐related procedures (e.g., embolization, access, adjunctive tools), though not a leading AAA stent‐graft brand.
↳ Focus in the broader vascular market enables supporting EVAR workflows (balloons, guidewires, closure devices) rather than core AAA stent‐grafts.

➢ Abbott Laboratories
↳ Not a major dedicated AAA stent‐graft player; its vascular presence centers on balloon‐expandable coronary and peripheral stents, diagnostics, and device‐adjacent technologies.
↳ May indirectly support AAA care via vascular access devices, embolization tools, and imaging‐enabled platforms, but no core AAA‐specific stent‐graft line.

➢ Becton Dickinson and Company (BD)
↳ Supplies vascular access and catheter‐based products (guidewires, sheaths, introducers) used in EVAR procedures rather than AAA‐specific stent‐grafts.
↳ Plays a support‐role supplier in the AAA/EVAR ecosystem, enabling delivery and access rather than structural repair.

➢ MicroPort Scientific Corporation
↳ Offers aortic stent‐grafts such as the Hercules® series (EVAR devices) for infrarenal AAA and peripheral applications.
↳ Markets domestic‐grown EVAR platforms in China and select international markets, targeting cost‐sensitive and mid‐tier hospital segments.

➢ Lifetech Scientific Corporation
↳ Provides Lifetech E‐type aortic stent‐grafts and Lifetech AAA stent‐graft systems for infrarenal and complex AAA.
↳ Focuses on low‐cost, modular EVAR platforms with ball‐and‐socket‐type connections and modular limbs for standard and challenging anatomies.

➢ JOTEC GmbH (Jotec, now part of Medtronic)
↳ Developed complex endografts such as the JOTEC E‐VITA and E‐type lines for thoracoabdominal and pararenal aneurysms, some applicable to AAA‐adjacent anatomy.
↳ These platforms are now largely integrated into Medtronic's high‐risk AAA and thoracoabdominal aneurysm portfolio.

➢ LeMaitre Vascular
↳ Primarily supplies vascular‐access and adjunctive devices (vascular clamps, grafts, patches, cutters) rather than AAA stent‐grafts.
↳ Supports open‐surgical AAA repair with peripheral vascular tools but does not offer a dedicated EVAR/AAA stent‐graft system.

➢ Artivion Inc.
↳ Focuses on cryopreserved human‐tissue vascular grafts and biologic products used in open aortic repair and complex reconstructions.
↳ In the AAA arena, Artivion mainly supports open‐surgical AAA graft‐replacement rather than endovascular stent‐grafts.

➢ Cordis Corporation
↳ Once a vascular‐intervention player, Cordis now contributes more to peripheral access and catheter‐based products than AAA‐specific stent‐grafts.
↳ Provides delivery‐related tools and catheters used in EVAR procedures, functioning as a workflow‐enabling supplier rather than a core AAA device brand.

Latest Industry Developments

🔹 W.L. Gore & Associates received CE Mark approval for its GORE VIABAHN VBX Balloon Expandable Endoprosthesis, improving flexibility in fenestrated and branched endovascular aneurysm repair (FEVAR and BEVAR) procedures.

🔹 Vivasure Medical received approval for its PerQseal Elite, a bioresorbable, sutureless vascular closure device, which reduces complications during EVAR and other minimally invasive procedures.

Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as North America, Europe, or Asia Pacific.

📥 Instant Report Delivery Available | 💳 Buy Now 👉 https://www.precedenceresearch.com/checkout/8243

Segments Covered in the Report

🔸 By Treatment Type

Endovascular Aneurysm Repair (EVAR)
Open Surgical Repair (OSR)

🔸 By Product Type

Stent Grafts/Endografts
Catheters & Delivery Systems

🔸 By Aneurysm Site

Infrarenal AAA
Pararenal AAA

🔸 By End-User

Hospitals
Ambulatory Surgical Centers (ASCs)
Specialty Clinics

🔸 By Technique (Advanced EVAR)

Standard EVAR
Fenestrated EVAR (FEVAR)
Branched / Hybrid EVAR

🔸 By Region

North America
Latin America
Europe
Asia-pacific
Middle and East Africa

Connect With Us

📞 USA: +1 804 441 9344
📞 APAC: +61 485 981 310 or +91 87933 22019 | +6531051271
📞 Europe: +44 7383 092 044
📩 Email: sales@precedenceresearch.com

Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

🌐 Web: https://www.precedenceresearch.com

Our Trusted Data Partners:
🔹https://www.towardshealthcare.com
🔹https://www.towardspackaging.com
🔹https://www.towardschemandmaterials.com
🔹https://www.towardsfnb.com
🔹https://www.marketstatsinsight.com

Get Recent News:
https://www.precedenceresearch.com/news

For the Latest Update, Follow Us:
🔹https://www.linkedin.com/company/precedence-research
🔹https://x.com/Precedence_R
🔹https://www.facebook.com/precedenceresearch
🔹https://precedence-research.medium.com/

This release was published on openPR.